Clinical Trial Update: A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of amrubicin and carboplatin with pegfilgrastim in extensive-stage small cell lung cancer has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Amrubicin (amrubicin)
• CARBOPLATIN (Carboplatin)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Extensive-Stage Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-12-10